Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2014
August 2014, Vol 5, No 6
August 2014, Vol 5, No 6
FDA Approved Idelalisib for 3 Types of Hematologic Cancers
FDA Approvals, News & Updates
August 2014, Vol 5, No 6
The FDA approved idelalisib (Zydelig; Gilead Sciences) for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL) to be used in combination with rituximab (Rituxan).
Read Article
Belinostat Approved for Peripheral T-Cell Lymphoma, an Aggressive Form of NHL
FDA Approvals, News & Updates
August 2014, Vol 5, No 6
The FDA approved belinostat (Beleodaq; Spectrum Pharmaceuticals) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma (NHL).
Read Article
Value Propositions
Value Propositions
,
Value Peer-spectives
August 2014, Vol 5, No 6
Value Propositions from the August 2014 issue of Value-Based Cancer Care.
Read Article
The 340B Program Dilemma: The Good, the Bad, and the Ugly
By
Craig Deligdish, MD
From the Editor
,
Value Peer-spectives
August 2014, Vol 5, No 6
The 340B Drug Pricing Program was a result of Public Law 102-585, the Veterans Health Care Act of 1992, which was codified as Section 340B of the Public Health Service Act.
Read Article
Patients with Cancer Need Psychosocial Support, Expression of Caring
By
Wayne Kuznar
August 2014, Vol 5, No 6
Los Angeles, CA—Patient comfort and emotional support are part of the quality components in value-based cancer care.
Read Article
2014 Oncology Pipeline Looks Impressive
By
Wayne Kuznar
Emerging Therapies
,
Personalized Medicine
August 2014, Vol 5, No 6
The cancer drug pipeline continues to boast many new therapies, reinforcing the recent trends of new and improved monoclonal antibodies and other classes of targeted therapies for different types of tumors.
Read Article
Determining the Value of Cancer Therapies: A Paradigm Shift Focused on Quality, Outcomes, and Cost
By
Winston Wong, PharmD
Payer’s Perspective
,
Value Peer-spectives
August 2014, Vol 5, No 6
According to the 2013 Annual Report on Progress Against Cancer published in 2014 by the American Society of Clinical Oncology (ASCO), cancer death rates have declined by 21% among men and by 12% among women since the 1990s, and more than 13 million cancer survivors are alive in the United States today.
Read Article
Medication Costs Impact Patient Adherence Even in Oncology, Affecting Quality Care
By
Eileen Koutnik-Fotopoulos
Economics of Cancer Care
August 2014, Vol 5, No 6
Nonadherence to medication has been associated with financial burden; however, little is known about the association between the discussion of cancer treatments between patients and oncologists regarding out-of-pocket cost and medication adherence.
Read Article
Zykadia (Ceritinib) Approved for the Treatment of Patients with Crizotinib-Resistant ALK-Positive Non–Small-Cell Lung Cancer
By
Lisa A. Raedler, PhD, RPh
Drug Updates
August 2014, Vol 5, No 6
Lung cancer is one of the most frequently diagnosed cancers, as well as the leading cause of cancer-related mortality in the United States.
Read Article
Page 4 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma